167 related articles for article (PubMed ID: 34958321)
41. Esthesioneuroblastoma: a contemporary review of diagnosis and management.
Bak M; Wein RO
Hematol Oncol Clin North Am; 2012 Dec; 26(6):1185-207. PubMed ID: 23116576
[TBL] [Abstract][Full Text] [Related]
42. DNA methylation-based classification of sinonasal undifferentiated carcinoma.
Dogan S; Vasudevaraja V; Xu B; Serrano J; Ptashkin RN; Jung HJ; Chiang S; Jungbluth AA; Cohen MA; Ganly I; Berger MF; Momeni Boroujeni A; Ghossein RA; Ladanyi M; Chute DJ; Snuderl M
Mod Pathol; 2019 Oct; 32(10):1447-1459. PubMed ID: 31186531
[TBL] [Abstract][Full Text] [Related]
43. Targeted 595-gene genomic profiling demonstrates low tumor mutational burden in olfactory neuroblastoma.
Friedman J; Schumacher JK; Papagiannopoulos P; Al-Khudari S; Tajudeen BA; Batra PS
Int Forum Allergy Rhinol; 2021 Jan; 11(1):58-64. PubMed ID: 32558242
[TBL] [Abstract][Full Text] [Related]
44. Molecular profiling of sinonasal undifferentiated carcinoma.
Gelbard A; Hale KS; Takahashi Y; Davies M; Kupferman ME; El-Naggar AK; Myers JN; Hanna EY
Head Neck; 2014 Jan; 36(1):15-21. PubMed ID: 23633104
[TBL] [Abstract][Full Text] [Related]
45. Sinonasal malignancies with neuroendocrine differentiation: patterns of failure according to histologic phenotype.
Rosenthal DI; Barker JL; El-Naggar AK; Glisson BS; Kies MS; Diaz EM; Clayman GL; Demonte F; Selek U; Morrison WH; Ang KK; Chao KS; Garden AS
Cancer; 2004 Dec; 101(11):2567-73. PubMed ID: 15517582
[TBL] [Abstract][Full Text] [Related]
46. Outcomes and patterns of failure for sinonasal undifferentiated carcinoma (SNUC): The Mayo Clinic Experience.
Gamez ME; Lal D; Halyard MY; Wong WW; Vargas C; Ma D; Ko SJ; Foote RL; Patel SH
Head Neck; 2017 Sep; 39(9):1819-1824. PubMed ID: 28561906
[TBL] [Abstract][Full Text] [Related]
47. Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022: SWI/SNF-deficient Sinonasal Neoplasms: An Overview.
Agaimy A
Head Neck Pathol; 2022 Mar; 16(1):168-178. PubMed ID: 35307773
[TBL] [Abstract][Full Text] [Related]
48. Role of p40 and cytokeratin 5/6 in the differential diagnosis of sinonasal undifferentiated carcinoma.
Singh L; Ranjan R; Arava S; Singh MK
Ann Diagn Pathol; 2014 Oct; 18(5):261-5. PubMed ID: 25017972
[TBL] [Abstract][Full Text] [Related]
49. Oral involvement of sinonasal undifferentiated carcinoma: A case report and immunohistochemical study of a challenging case.
Gonçalves JM; Scarini JF; Gondak R; Altemani A; Mariano FV
Oral Oncol; 2022 Mar; 126():105779. PubMed ID: 35183913
[TBL] [Abstract][Full Text] [Related]
50. Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis.
Miyamoto RC; Gleich LL; Biddinger PW; Gluckman JL
Laryngoscope; 2000 Aug; 110(8):1262-5. PubMed ID: 10942123
[TBL] [Abstract][Full Text] [Related]
51. Frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas.
Dogan S; Chute DJ; Xu B; Ptashkin RN; Chandramohan R; Casanova-Murphy J; Nafa K; Bishop JA; Chiosea SI; Stelow EB; Ganly I; Pfister DG; Katabi N; Ghossein RA; Berger MF
J Pathol; 2017 Aug; 242(4):400-408. PubMed ID: 28493366
[TBL] [Abstract][Full Text] [Related]
52. Among sinonasal tumors, CDX-2 immunoexpression is not restricted to intestinal-type adenocarcinomas.
Tilson MP; Gallia GL; Bishop JA
Head Neck Pathol; 2014 Mar; 8(1):59-65. PubMed ID: 23846317
[TBL] [Abstract][Full Text] [Related]
53. Facial disfigurement due to olfactory neuroblastoma: beauty regained with chemotherapy.
Kumar P; Sundriyal D; Bhandari R; Singh A; Jat B; Sehrawat A
Cancer Rep (Hoboken); 2021 Feb; 4(1):e1303. PubMed ID: 33029949
[TBL] [Abstract][Full Text] [Related]
54. Transcription Factor Expression in Sinonasal Neuroendocrine Neoplasms and Olfactory Neuroblastoma (ONB): Hyams' Grades 1-3 ONBs Expand the Spectrum of SATB2 and GATA3-Positive Neoplasms.
Uccella S; Facco C; Chiaravalli AM; Pettenon F; La Rosa S; Turri-Zanoni M; Castelnuovo P; Cerati M; Sessa F
Endocr Pathol; 2022 Jun; 33(2):264-273. PubMed ID: 35522392
[TBL] [Abstract][Full Text] [Related]
55. Gene Methylation Profiling in Sinonasal Adenocarcinoma and Squamous Cell Carcinoma.
Costales M; López-Hernández A; García-Inclán C; Vivanco B; López F; Llorente JL; Hermsen MA
Otolaryngol Head Neck Surg; 2016 Nov; 155(5):808-815. PubMed ID: 27301901
[TBL] [Abstract][Full Text] [Related]
56. Presentation and Outcomes of Non-Squamous Cell Carcinoma Sinonasal Malignancies: A National Perspective.
Al-Qurayshi Z; Liu A; Walsh JE
Ann Otol Rhinol Laryngol; 2022 Apr; 131(4):420-426. PubMed ID: 34137285
[TBL] [Abstract][Full Text] [Related]
57. [Diagnosis, prognosis and treatment of sinonasal carcinomas (excluding melanomas, sarcomas and lymphomas)].
Thariat J; Moya Plana A; Vérillaud B; Vergez S; Régis-Ferrand F; Digue L; Even C; Costes V; Baujat B; de Gabory L; Baglin AC; Janot F;
Bull Cancer; 2020 May; 107(5):601-611. PubMed ID: 32305127
[TBL] [Abstract][Full Text] [Related]
58. An atypical esthesioneuroblastoma of the inferior nasal cavity and maxillary sinus: report of a case.
Unal A; Ozlugedik S; Tezer MS; Kulacoglu S; Ozcan M
Tumori; 2006; 92(5):440-3. PubMed ID: 17168440
[TBL] [Abstract][Full Text] [Related]
59. IDH1/2 Mutations in Sinonasal Undifferentiated Carcinomas : Previously Undescribed IDH2 R172K and R140x Variants.
Kakkar A; Rathor A; Ashraf SF; Singh V; Sikka K; Jain D
Am J Surg Pathol; 2022 Sep; 46(9):1284-1290. PubMed ID: 35486703
[TBL] [Abstract][Full Text] [Related]
60. The role of systemic therapy in the management of sinonasal cancer: A critical review.
Bossi P; Saba NF; Vermorken JB; Strojan P; Pala L; de Bree R; Rodrigo JP; Lopez F; Hanna EY; Haigentz M; Takes RP; Slootweg PJ; Silver CE; Rinaldo A; Ferlito A
Cancer Treat Rev; 2015 Dec; 41(10):836-43. PubMed ID: 26255226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
